Caitlin Kontulis - 15 Feb 2023 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Secretary & VP Finance & Admin
Signature
Caitlin Kontulis
Issuer symbol
PHIO
Transactions as of
15 Feb 2023
Transactions value $
-$3,416
Form type
4
Filing time
17 Feb 2023, 17:30:20 UTC
Previous filing
03 Mar 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Tax liability -$3.42K -657 -7.59% $5.20 7.99K 15 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
F2 Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12.